Synthesis and biological evaluation of new pyrazolone–pyridazine conjugates as anti-inflammatory and analgesic agents
- 1 April 2014
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 22 (7), 2080-2089
- https://doi.org/10.1016/j.bmc.2014.02.042
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitorsBioorganic & Medicinal Chemistry, 2012
- Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophilsEuropean Journal of Medicinal Chemistry, 2011
- Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritisArthritis Research & Therapy, 2011
- Anti-inflammatory, Cyclooxygenase (COX)-2, COX-1 Inhibitory, and Free Radical Scavenging Effects ofRumex nepalensisPlanta Medica, 2010
- Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsGut, 2006
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Rheumatoid arthritis: developing pharmacological therapiesExpert Opinion on Investigational Drugs, 2004
- Anti-Cytokine Therapy for Rheumatoid ArthritisAnnual Review of Medicine, 2000
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996